About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of LY3039478 in Healthy Participants

NCT02659865·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Eli Lilly and Company

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

\- Body mass index (BMI) of 18 to 32 kilogram per meter square (kg/m²)

You may not be if

\- Known allergies to LY3039478, related compounds or any components of the formulation
Have previously received LY3039478
Smokers or who have stopped smoking less than 3 months prior to enrollment

The record

StatusCompleted

PhasePhase 1

Taking part29

StartedJan 2016

UpdatedAug 12, 2025

Conditions

Where1

Covance
Daytona Beach, Florida, United States

Clareo Health | A Study of LY3039478 in Healthy Participants